Award recordCONTRACT

GENZYME CORPORATION

PIID VA24416F1784· VHA· 244-NETWORK CONTRACT OFFICE 4 (36C244)· Q301 · MEDICAL- LABORATORY TESTING· FY2016· $99,200 net obligations· UEI X2XMAQLR9DA8· MA

Description

IGF::OT::IGF PATHOLOGY TESTING

First action · last action
2016-01-11 · 2016-12-21
Transactions
2
First transaction's obligation
$99,533
Base + all options value (sum of deltas)
$99,200
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2086D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$99,533$0Base award · 2016-01-11 · this action $99,533 · running total $99,533Modification P00001 · 2016-12-21 · this action -$333 · running total $99,200
  • Base2016-01-11+$99,533= $99,533
  • Mod P000012016-12-21-$333= $99,200
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-01-11+$99,533$99,533IGF::OT::IGF PATHOLOGY TESTING
Mod P00001· CLOSE OUT2016-12-21−$333$99,200IGF::OT::IGF PATHOLOGY TESTING

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26222F0606262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$20,049FY2022

Other recipients under Q301 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24426F0245CASTLE BIOSCIENCES, INC244-NETWORK CONTRACT OFFICE 4 (36C244)$164,395FY2026
36C24426N1026ROCHE DIAGNOSTICS CORPORATION244-NETWORK CONTRACT OFFICE 4 (36C244)$309,506FY2026
36C24426P0390UPMC PRESBYTERIAN SHADYSIDE244-NETWORK CONTRACT OFFICE 4 (36C244)$680,973FY2026
36C24426N0919PURE AIR UV INC.244-NETWORK CONTRACT OFFICE 4 (36C244)$27,440FY2026
36C24426N0922BECKMAN COULTER, INC244-NETWORK CONTRACT OFFICE 4 (36C244)$46,600FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24416F1784_3600_V797P2086D_3600 · retrieved 2026-09-26.